Cell and Gene Therapies Saw Banner Year, with New Indications on the Horizon

In terms of approvals of new products, 2021 was the second-best year for cell and gene therapies and tissue products (The best year was 2016, when nine therapies were approved.).
Source: Drug Industry Daily